Applied Finance Capital Management’s AbbVie ABBV Stock Holding History

Applied Finance Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.32M	Sell	25,128 -4,943	-16%	-$1.06M	0.47%	59
2026 Q1	$6.54M	Buy	30,071 +177	+0.6%	+$39.3K	0.49%	56
2025 Q4	$6.83M	Buy	29,894 +9,239	+45%	+$2.1M	0.49%	57
2025 Q3	$4.78M	Sell	20,655 -1,550	-7%	-$316K	0.34%	55
2025 Q2	$4.12M	Sell	22,205 -2,416	-10%	-$449K	0.28%	57
2025 Q1	$5.16M	Buy	24,621 +2,632	+12%	+$512K	0.38%	56
2024 Q4	$3.91M	Sell	21,989 -1,609	-7%	-$296K	0.17%	57
2024 Q3	$4.66M	Buy	23,598 +3,451	+17%	+$644K	0.2%	56
2024 Q2	$3.46M	Buy	20,147 +18,234	+953%	+$3.02M	0.16%	56
2024 Q1	$348K	Buy	+1,913	New	+$330K	0.02%	63

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Applied Finance Capital Management's ABBV Position: Q2 2026 in Review

Applied Finance Capital Management reduced its AbbVie (ABBV) stake by 16% in Q2 2026, selling an estimated $1.06M and leaving 25,128 shares worth $6.32M. The position accounts for 0.47% of the portfolio, ranked #59.

Applied Finance Capital Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.83M in Q4 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Applied Finance Capital Management held 25,128 shares of AbbVie worth $6.32M as of Q2 2026.
Applied Finance Capital Management sold 4,943 AbbVie shares in Q2 2026, an estimated $1.06M.
AbbVie made up 0.47% of Applied Finance Capital Management's portfolio in Q2 2026, its #59 holding.
Applied Finance Capital Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Applied Finance Capital Management's AbbVie position peaked at $6.83M in Q4 2025.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.